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On the other hand, more sophisticated models consisting of mass 
and isotope balances have been used to fit glutamine and gluta-
mate 13C time-courses from in vivo NMR experiments and estimate 
fluxes in relatively simple networks (Henry et al., 2006). These 
modeling studies have allowed estimating the main metabolic fluxes 
in the rodent or human brain: neuronal and glial tricarboxylic acid 
(TCA) cycle, glial anaplerotic PC flux (V
PC
), glutamate–glutamine 
cycle flux (V
NT
), and glutamate/α-ketoglutarate exchange rate (V
x
; 
Henry et al., 2006 and references therein). In addition, Patel et al. 
(2005) have developed a three compartment model (astrocytes, 
glutamatergic and GABAergic neurons) to estimate the contribu-
tion of GABAergic activity to cerebral energetics. More recently, 
Jolivet et al. (2009) reported a novel approach based on estimations 
of state-dependent brain energy budget for neurons and astrocytes 
using data sets of cerebral glucose and oxygen utilization during 
different brain activation states.
However, most current models do not consider flux routes 
that can contribute substantially to the observed isotopic labeling 
patterns. For instance, label dilution in glutamine and glutamate, 
IntroductIon
Isotopic labeling experiments and 13C nuclear magnetic resonance 
(NMR) spectroscopy have been extensively applied to investigate 
particular aspects of cerebral metabolism both in cell cultures 
(Merle et al., 1996a; Waagepetersen et al., 2003; Sonnewald et al., 
2004) and in vivo (Gruetter et al., 2001; Garcia-Espinosa et al., 2004; 
Hyder et al., 2006) due to the highly specific metabolic informa-
tion generated. The metabolism of a 13C-labeled substrate through 
different pathways originates distinct labeling patterns and 13C 
time-courses. These data can then be translated into quantitative 
metabolic fluxes using mathematical models. In fact, metabolic 
modeling was crucial to show the existence of metabolic compart-
mentation (Gruetter et al., 2001) and to determine the contribu-
tions from astrocytes (Lebon et al., 2002) and neurons (Hyder et al., 
2006) to the overall oxidative metabolism of glucose in the brain.
Simple mathematical models have been used to estimate the pyru-
vate dehydrogenase (PDH) and pyruvate carboxylase (PC) fluxes 
based on steady-state 13C fractional enrichment of glutamate or glu-
tamine (Malloy et al., 1988; Martin et al., 1993; Merle et al.,1996a). 
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Metabolic models have been used to elucidate important aspects of brain metabolism in recent 
years. This work applies for the first time the concept of isotopic transient 13C metabolic flux 
analysis (MFA) to estimate intracellular fluxes in primary cultures of astrocytes. This methodology 
comprehensively explores the information provided by 13C labeling time-courses of intracellular 
metabolites after administration of a 13C-labeled substrate. Cells were incubated with medium 
containing [1-13C]glucose for 24 h and samples of cell supernatant and extracts collected at 
different time points were then analyzed by mass spectrometry and/or high performance 
liquid chromatography. Metabolic fluxes were estimated by fitting a carbon labeling network 
model to isotopomer profiles experimentally determined. Both the fast isotopic equilibrium 
of glycolytic metabolite pools and the slow labeling dynamics of TCA cycle intermediates are 
described well by the model. The large pools of glutamate and aspartate which are linked to 
the TCA cycle via reversible aminotransferase reactions are likely to be responsible for the 
observed delay in equilibration of TCA cycle intermediates. Furthermore, it was estimated that 
11% of the glucose taken up by astrocytes was diverted to the pentose phosphate pathway. 
In addition, considerable fluxes through pyruvate carboxylase [PC; PC/pyruvate dehydrogenase 
(PDH) ratio = 0.5], malic enzyme (5% of the total pyruvate production), and catabolism of 
branched-chained amino acids (contributing with ∼40% to total acetyl-CoA produced) confirmed 
the significance of these pathways to astrocytic metabolism. Consistent with the need of 
maintaining cytosolic redox potential, the fluxes through the malate–aspartate shuttle and the 
PDH pathway were comparable. Finally, the estimated glutamate/α-ketoglutarate exchange rate 
(∼0.7 μmol mg prot−1 h−1) was similar to the TCA cycle flux. In conclusion, this work demonstrates 
the potential of isotopic transient MFA for a comprehensive analysis of energy metabolism.
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 usually attributed to metabolite exchange between brain and blood, 
could actually derive from the pentose phosphate pathway (PPP) 
or oxidation of fatty acids or of poorly labeled amino acids that 
might result from proteolysis (Dienel and Cruz, 2009; Shen et al., 
2009). These are usually not considered to avoid an increase in 
the complexity of the metabolic network. Consequently, a larger 
amount of data would be required to reliably identify all unknown 
fluxes, which is difficult when working in vivo. Therefore, many 
assumptions are generally used to determine metabolic fluxes in 
vivo. However, this issue has raised concern about the reliability of 
estimated fluxes based on isotopomers derived from 13C glucose 
metabolism (Shestov et al., 2007).
In contrast to the metabolic modeling tools referred above, a 
more comprehensive metabolic picture can be provided by meta-
bolic flux analysis (MFA), one of the first tools targeting systems 
level analysis of intracellular fluxes in microbial and animal cell 
cultures (Varma and Palsson, 1994; Lee et al., 1999; Quek et al., 
2010). This methodology requires the definition of material-bal-
ance equations for all metabolites included in the network. Then, 
by measuring a sufficient number of metabolite consumption/pro-
duction rates in cell culture supernatants, intracellular fluxes can 
be estimated based on the network’s stoichiometry and assuming 
intracellular steady-state (Lee et al., 1999). This implies that the 
sum of the fluxes leading to the synthesis and consumption of each 
metabolite is equal to zero and, consequently, intracellular metabo-
lite pools will be constant. Using a simple network, we have recently 
characterized the effects of hypoglycemia on metabolic fluxes of 
cultured cerebellar neurons using MFA (Amaral et al., 2011).
Still, MFA based on metabolite balancing alone does not allow 
well-resolved flux distributions, as the fluxes through parallel path-
ways or reversible reactions cannot be distinguished. To improve 
flux resolution, classical MFA has been complemented with 13C 
labeling data collected at isotopic steady-state. This has been applied 
by our group to characterize the metabolism of astrocytic cultures 
under normal conditions and after an ischemic episode (Teixeira 
et al., 2008; Amaral et al., 2010). In these studies, the steady-state 
label distribution in certain metabolites in the culture medium 
was analyzed and this information used to elucidate flux ratios in 
parallel routes that contribute differently to label distribution, such 
as the flux ratio of PC to PDH or the flux ratio of glycolysis to PPP.
Recently, Wiechert and Noh (2005) introduced the concept of 
non-stationary 13C MFA. In this methodology the metabolic steady-
state is also assumed but the isotopic transient state (i.e., the time 
period during which the 13C label is being distributed by the differ-
ent metabolite isotopomers until isotopic steady-state is reached) 
in intracellular metabolites is taken into consideration. In this case, 
mass isotopomers are analyzed at different time points, normally 
using sensitive mass spectrometry (MS) techniques, to follow 
the label incorporation immediately after incubating cells with a 
labeled substrate (Hofmann et al., 2008). Current developments in 
MS enable a precise assessment of 13C labeling in several metabolites 
of the main pathways of carbon metabolism in a relatively small 
sample volume (Noh et al., 2007). Subsequently, to translate the 
time-series labeling data into metabolic fluxes, such mathemati-
cal models combine balances of the total metabolite pools and 
of individual isotopomers, containing full information about the 
transition of the labeled carbons within metabolites (Wiechert and 
Noh, 2005; Noh et al., 2007). Model inputs are isotopomer 13C time-
courses and some metabolite pools determined experimentally, in 
addition to the consumption or production rates of metabolites 
measured in cell supernatants. Isotopic transient MFA has been 
successfully applied to estimate fluxes in prokaryotic and mam-
malian cell systems (Schaub et al., 2008; Metallo et al., 2009). When 
comparing to the classical MFA, it has as main advantages not rely-
ing on uncertain cofactor balances and allowing the estimation of 
fluxes through both parallel and cyclic pathways as well as through 
bidirectional reactions (Wiechert and Noh, 2005). It is, however, 
experimentally and computationally more demanding, requiring 
the solution of a large number of differential equations (Noh and 
Wiechert, 2006; Noh et al., 2006).
Hence, the main aim of this study was to apply for the first 
time the isotopic transient 13C MFA methodology to the study of 
astrocytic metabolism in order to obtain an integrated picture of 
their metabolic fluxes. This was achieved by fully exploring the iso-
topic transient information collected after [1-13C]glucose admin-
istration to primary cultures of astrocytes. Quantification of the 
labeling time-courses was accomplished by gas chromatography–
MS (GC–MS) and metabolites pool sizes were measured by high 
performance-liquid chromatography (HPLC). A comprehensive 
metabolic network including glycolysis, PPP, TCA cycle, and amino 
acids metabolism was considered to fit metabolite 13C time-courses 
and estimate metabolic fluxes. This approach allowed estimat-
ing important metabolic fluxes of astrocytes with high statistical 
quality and provided valuable information on the contribution 
of other sources than glucose to the main pathways of astrocytic 
energy metabolism. Thus, it represents a powerful and new tool to 
investigate still unclear aspects of brain metabolism or metabolic 
responses of cultured cells to pathological conditions, which can 
be further explored in vivo.
MaterIals and Methods
MaterIals
Plastic tissue culture dishes were purchased from Nunc (Roskilde, 
Denmark); fetal bovine serum (FBS), penicillin–streptomycin 
( Pen-Strep) solution, and Dulbecco’s modified Eagle’s Medium 
(DMEM) were purchased from GIBCO, Invitrogen (Paisley, 
UK); 13C-labeled glucose was purchased from Cambridge Isotope 
Laboratories (Andover, MA, USA); N-Methyl-N-(t-Butyldimethylsilyl)
trifluoroacetamide (MTBSTFA) + 1% t-butyldimethylchlorosilane 
(t-BDMS-Cl) was purchased from Regis Technologies (Morton Grove, 
IL, USA); toluene and acetonitrile were purchased from LabScan 
(Gliwice, Poland); all other chemicals were purchased from Sigma-
Aldrich (Munich, Germany). Animals were purchased from Instituto 
de Higiene e Medicina Tropical (Lisbon, Portugal).
cell culture and MetabolIte extractIon
Primary cultures of cortical astrocytes were obtained from 1- to 
2-day-old rats and prepared as described previously (Richter-
Landsberg and Besser, 1994). Cells were cultured in DMEM con-
taining 5 mM glucose and supplemented with Pen-Strep (100 U/
mL) and 20% (v/v) FBS, gradually reducing its concentration to 
10%. Cultures were kept in a humidified atmosphere with 7% CO
2
 
in air and 37°C. After 3 weeks in culture, cells were trypsinized 
and seeded into six-well plates at a cell density of 5 × 104 cells/cm2. 
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All samples were analyzed on an Agilent 6890 gas chromatograph 
with a capillary column (WCOT fused silica 25 mm × 0.25 mm ID, 
0.25 μm film thickness, VF-1ms, Varian), connected to an Agilent 
5975B mass spectrometer with electron impact ionization. Atom 
percent excess (13C) in the different metabolites was determined 
after calibration using unlabeled standard solutions (Biemann, 
1962). Mass isotopomers differ by the number of labeled carbons; 
m represents the fraction of unlabeled compound in the total com-
pound pool, m + 1 the fraction of compound labeled in one carbon 
and so on. All fractions of a metabolite sum up to 100%.
IsotopIc transIent 13c MetabolIc Flux analysIs
Metabolic network and metabolite balancing
According to the main changes observed intracellularly and in 
the culture supernatant, a metabolic network was established to 
represent the metabolism of astrocytes (Figure 1). The network 
comprises the following metabolic pathways: glycolysis, PPP, TCA 
cycle, malate–aspartate shuttle (MAS), catabolism of some amino 
acids, and synthesis of glutathione, glutamine, alanine, and taurine/
hypotaurine. It contains 32 balanced intracellular metabolites and 
a total of 47 fluxes, from which three were considered reversible.
Isotopic transient MFA relies in both metabolite and mass iso-
topomers balancing. If the metabolic network has m metabolites 
and q reactions, the following steady-state material balances can 
be formulated (Eq. 1):
Nr = 0  (1)
with N being a m × q stoichiometric matrix, and r the vector of q 
metabolic rates.
Modeling of isotopomer 13C time-courses
After administration of the labeled substrate, the mass isoto-
pomer distribution of each metabolite changes over time depend-
ing on the flux distribution. To represent mathematically the 
system and estimate the unknown fluxes, a set of differential 
equations needs to be established for each isotopomer, fulfilling 
the stoichiometric constraints of the metabolic network. Carbon 
transitions occurring in biochemical reactions are well estab-
lished for the majority of metabolic pathways and documented 
in biochemistry textbooks. Eqs 2 and 3 represent the balances 
for the two mass isotopomers of glucose, when [1-13C]glucose 
is the labeled substrate:
d
dt
Glc
Glc
r Glcm
pool
m= − ⋅( )1 1  (2)
d
dt
Glc
Glc
r r Glcm+1
pool
Glc m+1= − ⋅( )1 1  (3)
where Glc
m
 is the fraction of unlabeled glucose, Glc
m + 1
 is the frac-
tion of glucose labeled in one carbon, Glc
pool
 is the intracellular 
glucose pool, r
Glc
 is the uptake rate of glucose, and r
1 
is the flux 
through reaction 1. The equations for the remaining intracellular 
metabolites are listed in Appendix.
[1-13C]glucose is taken up by astrocytes and subsequently 
metabolized either via PPP, where the labeled carbon is lost as 
CO
2
, or via glycolysis, labeling 3PG, PEP, and pyruvate in carbon 
Experiments were performed when cells reached confluence: the 
culture medium was removed, cells were washed with phosphate-
buffered saline (PBS) and subsequently incubated with DMEM 
with 1% FBS containing 4 mM [1-13C]glucose (2 ml of culture 
medium per well). The transient period of label incorporation into 
intracellular metabolites was followed during 24 h, using a shorter 
sampling time in the beginning. Samples of medium and cell con-
tent were collected at 0, 6, 12, 30 min, 1, 2, 4, 7, 10, 16, and 24 h after 
labeled glucose administration. Experiments were run in triplicate. 
The cell supernatant was collected, centrifuged at 200 × g for 10 min 
and stored at −20°C until further analysis. Cell monolayers were 
washed with cold PBS to eliminate tracer amounts of extracellular 
metabolites, frozen in liquid nitrogen to rapidly stop metabolism 
and extracted with 70% (v/v) ethanol, followed by centrifugation 
at 20,000 × g for 15 min. The resulting supernatants (cell extracts) 
were stored at −80°C until GC–MS or HPLC analysis. The pellets 
were stored at −20°C and were later used either for protein analysis.
QuantIFIcatIon oF extra- and Intracellular MetabolIte 
concentratIons
Glucose and lactate concentrations in samples of cell supernatants 
were determined using an automated YSI 7100 Multiparameter 
Bioanalytical System (Dayton, OH, USA). Intra- and extracellu-
lar concentrations of amino acids were quantified by HPLC using 
a pre-column derivatization method based on the Waters AccQ.
Tag Amino Acid Analysis method as described elsewhere (Amaral 
et al., 2010).
proteIn QuantIFIcatIon
The total cellular protein content was determined by dissolving 
the cell pellets in 0.1 M NaOH followed by incubation overnight 
at 37°C, to ensure complete protein extraction. The bicinchoninic 
acid protein assay from Pierce (Rockford, IL, USA) was used to 
determine total protein amounts using bovine serum albumin as 
standard.
QuantIFIcatIon oF Mass IsotopoMers by Gc–Ms
For analysis of lactate, amino acids (alanine, aspartate, glutamate, 
and glutamine), and TCA cycle intermediates (α-ketoglutarate, 
fumarate, and malate), samples of cell extracts and cell superna-
tants were lyophilized and dissolved in 0.01 M HCl followed by 
pH adjustment to pH < 2 with 6 M HCl. The samples were then 
dried under atmospheric air (50°C). The metabolites were extracted 
into an organic phase of ethanol and benzene and dried again 
under atmospheric air (50°C). N,N-Dimethylformamide (DMF) 
was added before derivatization with MTBSTFA in the presence 
of 1% t-BDMS-Cl (Mawhinney et al., 1986). It was not possible to 
obtain consistent values for the enrichment of intracellular lactate.
The protocol used for analysis of the glycolytic intermediates 
phosphoenolpyruvate (PEP) and 3-phosphoglycerate (3PG), was 
based on that described in (Hofmann et al., 2008). Samples of 
cell extracts were lyophilized, dissolved in methanol, and dried 
under atmospheric air (50°C). The metabolites were then extracted 
with toluene and dried again under atmospheric air (50°C). 
Derivatization was performed using a mixture of N-Methyl-N-
(trimethylsilyl)trifluoroacetamide (MSTFA) + 1% trimethylchlo-
rosilane and acetonitrile.
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(m and m + 1), three isotopomers for pyruvate, lactate, alanine, 
and acetyl-CoA (m, m + 1, and m + 2), and four isotopomers (m, 
m + 1, m + 2, and m + 3) for the TCA cycle intermediates and 
remaining amino acids. In total, the system is represented by 96 
differential equations.
Labeling time-courses are influenced by the pool sizes of the 
metabolites. If these pools are not measured then they must be 
considered as unknown parameters in the model. On the other 
hand, lumping reactions in linear pathways cannot be done if 
the involved metabolites have different pool sizes. As they take 
different times to reach isotopic steady-state, lumping such reac-
tions can perturb the fitting to the experimental data and falsify 
flux estimations. It should be mentioned that no intracellular 
compartments were distinguished as it is still unfeasible to quan-
tify separately metabolite concentrations in different compart-
ments. Therefore, only one single pool was considered for each 
 intracellular metabolite.
number 3. [3-13C]pyruvate can be converted to [3-13C]lactate or 
[3-13C]alanine, be transported into mitochondria to enter the 
TCA cycle as [2-13C]acetyl-CoA via pyruvate dehydrogenase or 
as [3-13C]oxaloacetate by anaplerosis through the pyruvate car-
boxylation pathway (Shank et al., 1985). Condensation of [2-13C]
acetyl-CoA with unlabeled oxaloacetate will, after several steps, 
lead to the formation of [4-13C]glutamate and to either [2-13C]- 
or [3-13C]aspartate after the symmetrical succinate step. These 
compounds have one 13C atom and are thus detected as m + 1 
isotopomers in GC–MS. If labeled oxaloacetate condenses with 
labeled acetyl-CoA, double labeled metabolites are formed and 
they will be detected as m + 2 in GC–MS. Eventual cycling of the 
labeled compounds in the TCA cycle may lead to the synthesis of 
triple labeled metabolites (m + 3) after condensation of double 
labeled oxaloacetate with [2-13C]acetyl-CoA. From the 13C-labeling 
time-courses experimentally observed by GC–MS analysis, we have 
considered two isotopomers for glycolysis and PPP intermediates 
Figure 1 | Network representing astrocytic metabolism (the 
stoichiometry of the reactions can be found in Appendix). Abbreviations: 
Glc, glucose; G6P, glucose-6-phosphate; F6P, fructose-6-phosphate; DHAP, 
Dihydroxy-acetone phosphate; GAP, glyceraldehyde-3-phosphate; BPG, 
1:3-bis-phosphoglycerate; 3PG, 3-phosphoglycerate, 2PG, 2-phosphoglycerate; 
PEP, phosphoenolpyruvate; PYR, pyruvate; 6PGL, 6-phospho-gluconolactone; 
6PG, 6-phosphogluconate; Ru5P, ribulose-5-phosphate; R5P, ribose-5-phosphate; 
Xu5P, xylulose-5-phosphate; S7P, sedoheptulose-7-phosphate; E4P, erythrose-4-
phosphate; Lac, lactate; Glu, glutamate; ACoA, Acetyl-Coenzyme A; Cyst, 
cystine; Cys, cysteine; Gly, glycine; GSH, glutathione; Ala, alanine; α-KG, 
α-ketoglutarate; OAA, oxaloacetate; Cit, Citrate; Aco, cis-aconitate; Isocit, 
isocitrate; OSuc, oxalosuccinate; SucCoA, succinyl-coenzyme A; Succ, 
succinate; Fum, fumarate; Mal, malate; Aspm, aspartate – mitochondrial pool; 
Aspc, aspartate – cytosolic pool; Gln, glutamine; Leu, leucine; Ile, isoleucine; Val, 
valine; Lys, lysine; ext refers to metabolites taken up from/released to the 
medium.
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 important part of this estimation. Parameter uncertainty is assessed 
by its covariance. Assuming that the solution converges to a global 
minimum, the Hessian matrix H can be approximated from the 
Jacobian matrix J as follows:
H J J= T  (5)
The Jacobian matrix includes the partial derivatives of the model 
output with respect to the model parameters evaluated at each 
data point. The covariance matrix (cov) can then be estimated as
cov = ⋅ −RMSE H 1  (6)
with RMSE being the root mean squared error.
The confidence interval for each parameter p
i
 is obtained from 
the estimate of the SD σi i i= cov ,
/1 2 as follows:
CIi i i T pp= ± ⋅ −σ t 0 975. ,  (7)
with t
0.975,T−p
 being the t-student’s distribution for T−p (the number 
of measured data points minus the number of parameters) degrees 
of freedom and probability 0.975.
Sensitivity analysis
To investigate the possibility of accurately identifying each model 
parameter on the basis of the available experimental data, a sensi-
tivity analysis must be performed. The sensitivity coefficient, Sens
i
, 
reveals how the objective function F (Eq. 4) will be influenced by 
a differential change in the parameter p
i
.
Sens
F
Fi
= ∂
∂
pi
pi
 
(8)
The goal is to determine how “sensitive” the mathematical model 
is to changes in the value of its parameters. Small sensitivities, i.e., 
large changes in the parameter value resulting in small changes in 
the minimized sum of squared residuals, indicate that the parameter 
cannot be estimated accurately. Large sensitivities, on the other hand, 
indicate that the parameter can be estimated with high confidence.
Parameter estimation
For parameter identification, an optimization routine iteratively 
minimizes the function (F) represented in Eq. 4, until an acceptable 
small value is achieved. F is a variance-weighted difference between 
mass isotopomer measurements (I
m
) and model predictions (I
p
). 
Mass isotopomer data, I
m
, from the different metabolites collected 
at the time points indicated above (0, 6, 12, 30 min, 1, 2, 4, 7, 10, 16, 
and 24 h) were used for model fittings. As the various isotopomer 
profiles are measured with different accuracies, the errors must be 
weighted by the corresponding SDs:
p
m i p i
ii
n
t
T
T n
I t I t
min
( ) ( ), ,F =
×
−








==
∑∑1
2
11 σ
 
(4)
where p is the vector of parameters, T is the number of meas-
ured time points, n is the number of mass isotopomers and σi
2 
the variances of the mass isotopomer measurements. The set of 
fluxes and unmeasured pools corresponding to the minimum 
value of Eq. 4 is the solution for the flux calculation problem. 
To solve this optimization problem a quasi-Newton optimizer 
was employed (fmincon function from MATLAB™). As gradi-
ent algorithms are prone to converge to local optima, the opti-
mization was repeated systematically with different parameter 
starting values in order to increase the probability of reaching 
the global optimum. The initial parameter set was selected to be 
consistent with available primary literature on astrocytic metab-
olism. We then screened each initial parameter guess within a 
biologically relevant range, and chose the optimum parameter 
minimizing Eq. 4.
Computationally, it is more efficient to work with a set of 
independent fluxes, also called free fluxes, rather than with all 
metabolic fluxes (Wiechert and de Graaf, 1997). From the 47 
fluxes composing the metabolic network, 10 were experimentally 
measured (glucose, lactate, alanine, glutamine, leucine, isoleu-
cine, valine, cystine production, or consumption rates) or taken 
from literature (citrate and glutathione release rates; see below 
– Tables 1 and 4). Since the rank of the stoichiometric matrix 
is 31, there are six free fluxes (37–31) that need to be estimated; 
the remaining fluxes are subsequently calculated through linear 
combinations of these independent fluxes. Several pool sizes could 
not be experimentally measured and it is not possible to estimate 
those for which experimental 13C time-courses are also not avail-
able. Since published data on absolute pool concentrations is still 
limited, the pools of acetyl-CoA and all glycolytic and PPP inter-
mediates were considered equivalent and the average pool size 
(Glycolysis/PPP pool) was included in the group of parameters 
to be estimated. Regarding the TCA cycle intermediates for which 
mass isotopomer data was not available, an average pool size was 
tuned by trial-and-error and set equal to 0.03 μmol mg−1 protein. 
In total, 11 parameters (six free fluxes and five pool sizes) were 
estimated by fitting the model to the experimentally observed 
labeling dynamics.
Parameter confidence limits
Since parameter estimation involves a variety of possible errors, 
including measurements, modeling, and numerical errors, 
uncertainty analysis of the optimized parameters constitutes an 
Table 1 | experimentally measured values for intracellular pools of some 
amino acids and transmembrane rates of glucose, lactate, and amino 
acids whose concentration changed significantly during incubation 
time (negative values refer to consumption rates).
Specific transmembrane rates rGlc −1.06 ± 0.05 
(μmol mg prot−1 h−1) rLac 2.11 ± 0.10
 rGln 0.049 ± 0.005
 rAla 0.042 ± 0.004
 rVal −0.053 ± 0.005
 rIle −0.10 ± 0.05
 rLeu −0.11 ± 0.05
 rCyst −0.36 ± 0.04
Intracellular pools Ala 0.18 ± 0.04 
(μmol mg prot−1) Glu 0.18 ± 0.04
 Gln 0.08 ± 0.02
 Asp 0.15 ± 0.03
Ala, alanine; Asp, aspartate; Cyst, cystine; Glc, glucose; Gln, glutamine; Glu, 
glutamate; Ile, isoleucine; Lac, Lactate; Leu, leucine; Val, valine.
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experIMental 13c labelInG tIMe-courses
Samples of cell extracts were collected during the isotopic transient 
period in order to characterize labeling dynamics of intracellular 
metabolites of astrocytes using GC–MS. The metabolites analyzed 
include the glycolytic intermediates PEP and 3PG, the TCA cycle 
intermediates citrate, α-ketoglutarate, fumarate, and malate, and the 
amino acids alanine, glutamine, glutamate, and aspartate. Glycolytic 
intermediates reached isotopic steady-state much faster than TCA 
cycle intermediates (Figure 2). After addition of labeled glucose, 
the fraction of the unlabeled pools of PEP and 3PG decreased very 
fast, reaching isotopic steady-state within less than 30 min with 
an enrichment of 45% in m + 1. Regarding alanine, it seems that 
isotopic steady-state was not reached within the 24 h of incubation. 
At this time, 31% of the pool was labeled in one carbon. Citrate, 
the first TCA cycle intermediate after acetyl-CoA condenses with 
oxaloacetate, reached 45% of isotopic enrichment (m + 1 and m + 2) 
whereas the enrichment in fumarate was about 15% less (Figure 2). 
In addition, the labeled pools of malate and aspartate were very simi-
lar and slightly more enriched than that of fumarate. Furthermore, 
labeling time-courses of α-ketoglutarate, glutamate and glutamine 
were comparable but slower than that of citrate. It is noteworthy 
that synthesis of m + 2 and m + 3 mass isotopomers was observed 
for most of the TCA cycle intermediates analyzed, representing up 
to 8% of the total pools, for citrate and glutamate. This suggests 
that some mass isotopomers are formed after condensation of 
13C-labeled acetyl-CoA with 13C-labeled oxaloacetate.
13C enrichment of extracellular metabolites was also analyzed at 
the end of the incubation time (Table 2). The difference between 
% 13C enrichment in lactate and alanine (34 vs. 24% m + 1, respec-
tively) can be surprising given their common origin – pyruvate, sug-
gesting metabolic compartmentation (see Discussion). Moreover, 
alanine enrichment in the culture medium differed significantly 
from its intracellular enrichment. Extracellular citrate was ∼30% 
enriched in m + 1, which is similar to the data obtained for its 
intracellular pool, the same being observed for glutamine.
Flux estIMatIons by IsotopIc transIent 13c MFa
Intracellular flux estimations were obtained by minimizing the dif-
ference between model simulations and experimentally observed 
isotopomer profiles. The optimal fittings to the 13C labeling time-
courses of the 10 metabolites experimentally analyzed are shown 
in Figure 2. For some metabolites, the enrichment in heavy mass 
isotopomer fractions (m + 2 and m + 3) was detectable but with very 
low values (<1% above natural abundance) and with large associ-
ated SDs. Therefore, they were not considered in model fitting. 
Estimated parameters together with their 95% confidence inter-
vals are presented on Table 3. The remaining intracellular fluxes 
were calculated from the estimated free fluxes and are shown in 
Table 4. Both the fast labeling dynamics of PEP and 3PG and the 
slow dynamics of TCA cycle-related metabolites were well described 
by the model (Figure 2). However, the predicted labeling time-
courses of  alanine differed from experimental data to some extent. 
Different model structures were attempted to improve fittings for 
alanine; for instance, reaction r
10
 was turned reversible, but a null 
flux was identified for inverse reaction. These results suggest that 
labeling of the alanine pool is more complex than that described 
by our model and is probably related to the existence of  different 
results
Primary cultures of astrocytes were incubated with [1-13C]glucose 
and, during 24 h, samples of culture supernatant and cell con-
tent were collected at different time points, in order to estimate 
astrocytic metabolic fluxes and characterize metabolite labeling 
dynamics. This time window was enough to ensure isotopic 
steady-state in almost all intracellular metabolites analyzed by 
GC–MS.
specIFIc rates oF consuMptIon/productIon oF Glucose, 
lactate, and aMIno acIds
Consumption or secretion rates of relevant compounds were 
determined based on the changes of their concentrations in the 
culture medium (Table 1). It is generally accepted that glucose 
is the main energy substrate for the brain and also for astrocytes 
under physiological conditions (Zwingmann and Leibfritz, 2003). 
In agreement with previous studies, glucose was consumed at 
a constant rate of 1.06 ± 0.05 μmol mg prot−1 h−1, representing 
about 70% of the total carbon taken up by astrocytes. Amino acid 
analysis showed a decrease in the extracellular levels of the three 
branched chain amino acids (BCAA) isoleucine, leucine, and, to a 
lesser extent, valine. Consumption of these amino acids by astro-
cytes under physiological conditions has also been reported by 
other authors (Yudkoff et al., 1996; Johansen et al., 2007; Murin 
et al., 2009). Furthermore, cystine levels decreased in the super-
natant, with an uptake rate larger than that of BCAA. Cystine 
is the precursor for cysteine, and both amino acids can be used 
for the biosynthesis of glutathione, taurine, and hypotaurine in 
astrocytes (Brand et al., 1998; Kranich et al., 1998). Lactate, ala-
nine, and glutamine were steadily released by astrocytes during 
incubation. GC–MS analysis of the supernatant at the end of the 
experiment confirmed the release of these compounds, providing 
the fractional enrichment of each isotopomer (Table 2; see next 
sub-section). Citrate secretion was also evident from the GC data. 
However, its release rate could not determined because the GC–MS 
method used in this work only provides the relative abundance 
of isotopomers, not the total concentrations. Consequently, the 
release rate of 0.025 μmol mg prot−1 h−1, reported by (Westergaard 
et al., 1994) was used for modeling purposes. Intracellular amino 
acid pools were measured by HPLC and are listed in Table 1. 
Cellular growth was negligible during the time frame considered 
as  indicated by the amount of protein measured in different cell 
samples (0.126 ± 0.009 mg protein/well).
Table 2 | Percent 13C enrichment in extracellular metabolites.
Metabolite % 13C enrichment (m + 1)
Lactate 33.5 ± 0.7
Alanine 24.1 ± 2.2
Glutamine 28.84 ± 0.04
Citrate 30.7 ± 0.3
Primary cultures of cortical astrocytes were incubated with medium containing 
4 mM [1-13C]glucose for 24 h. Percent 13C enrichment in different extracellular 
metabolites was analyzed by mass spectrometry in samples of culture 
medium collected at the end of the incubation period. Results are presented as 
means ± SD in atom percent excess (n = 3).
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be  anticipated based on the 45% enrichment in m + 1 of PEP and 
3PG at isotopic steady-state, as further sources of label dilution 
in upper glycolytic metabolites (like glycogen degradation) were 
not considered in the model. In fact, [1-13C]glucose metabolism 
through the PPP leads to the loss of 13C as CO
2 
(r
14
). Subsequently 
formed metabolites might re-enter glycolysis at the 3-phosphate-
glyceraldehyde node, consequently diluting the enrichment of 
downstream metabolites.
Furthermore, 14% 13C enrichment for acetyl-CoA was predicted 
at isotopic steady-state (data not shown). Even though pyruvate 
was estimated to be 41% enriched, the synthesis of acetyl-CoA 
as a consequence of the metabolism of leucine and isoleucine 
(from incubation medium) dilutes the enrichment in this pool. 
Moreover, the model estimated the anaplerotic flux through PC as 
being 0.07 ± 0.02 μmol mg prot−1 h−1 (Table 4) and the flux through 
PDH as being 0.14 ± 0.07 μmol mg prot−1 h−1 (Table 4), which gives a 
pyruvate pools (discussed below). The average error between 
measured and predicted mass isotopomer profiles of the remain-
ing metabolites was below 3%. The reason for the small devia-
tions between α-ketoglutarate time-courses and model predictions 
might be worth to investigate further. According to the metabolic 
network adopted, α-ketoglutarate and glutamate are constantly 
being inter-converted, implying that the different isotopomers of 
both metabolites reach the same steady-state values. However, the 
unlabelled pool of α-ketoglutarate seems to be systematically ∼4% 
higher than that of glutamate, also at isotopic steady-state. This 
is probably due to cellular compartmentalization not taken into 
account by the metabolic network adopted.
Concerning the estimated fluxes, astrocytes showed a high 
glycolytic flux, converting most of the glucose to lactate. In 
addition, the model estimated that 11% of the glucose flux was 
diverted to the PPP (r
12
). Some activity through the PPP could 
Figure 2 | Mass isotopomers distribution after incubation of primary 
cultures of astrocytes with DMeM containing [1-13C]glucose. Diamonds 
– m; triangles – m + 1; circles – m + 2; squares m + 3. Experimental data 
obtained for m + 3 isotopomers of glutamine, fumarate, malate, and aspartate 
were below 0.5% 13C enrichment and therefore are not presented. Symbols 
are average values of GC–MS analysis of cell extracts from three parallel 
cultures of astrocytes; error bars correspond to SDs; lines are model 
predictions.
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statIstIcal sIGnIFIcance oF estIMated Fluxes and pool sIzes
After estimation of the free fluxes, their statistical validity must 
be evaluated. Besides the confidence limits (Table 3), also the 
sensitivity coefficients were derived for each parameter. All 
free fluxes presented small confidence intervals showing low 
uncertainty. Moreover, sensitivity coefficients higher than 1 
were obtained for all fluxes and pool sizes (data not shown). A 
sensitivity coefficient equal to 1 means that a variation of 10% 
in the corresponding parameter affects the function F (Eq. 4) 
in 10%. Thus, sensitivity coefficients higher than 1 mean that 
the model is sensitive to the parameter value, and indicate that 
the free fluxes were identified with good precision. Together 
with intracellular fluxes, intracellular pool sizes determine the 
isotopomer profiles of the various metabolites during incuba-
tion time; thus, the pool sizes which were not experimentally 
determined had to be estimated by model fitting to the experi-
mental data (Table 3). The average pool for glycolytic and PPP 
intermediates was estimated as 0.027 ± 0.001 μmol mg prot−1. 
The small confidence interval for this pool shows its statistical 
validity. The citrate and α-ketoglutarate pools could also be 
estimated with reasonable statistical confidence. The same is 
not true for fumarate and malate pools, presenting wide con-
fidence intervals.
PC/PDH ratio of 0.5. The model also estimated the flux through the 
MAS (0.16 μmol mg prot−1 h−1). Regarding the flux for the conver-
sion of malate into pyruvate (r
32
 – malic enzyme), it was estimated 
as being 0.12 ± 0.03 μmol mg prot−1 h−1 (Table 3). Furthermore, the 
experimentally measured uptake rate of cystine would significantly 
dilute the labeling dynamics of pyruvate and subsequently formed 
metabolites, if that would be its only metabolic fate. However, it 
is known that the major metabolic products of cystine/cysteine 
in astrocytes are taurine and hypotaurine (Brand et al., 1998), in 
addition to being a rate-limiting substrate in the biosynthesis of 
glutathione (Dringen and Hirrlinger, 2003). Thus, these differ-
ent fates of cysteine were included in the model (reactions 37 and 
38). Glutathione synthesis was set to 0.030 μmol mg prot−1 h−1, as 
reported in the literature for physiological conditions (O’Connor 
et al., 1995), and the model estimated a net rate of taurine and 
hypotaurine synthesis (r
38
 – 0.17 ± 0.02 μmol mg prot−1 h−1 – 
Table 3) as well as the fraction which is converted into pyruvate 
(r
20
 – 0.16 ± 0.01 μmol mg prot−1 h−1 – Table 4) in order to have a 
cysteine to pyruvate rate that would fit better with the observed 
labeling dynamics.
This approach additionally enabled to estimate the fluxes of 
exchange between α-ketoglutarate and glutamate (Tables 2 and 3; 
Figure 3), which were similar to the TCA fluxes. Interestingly, a net 
flux favoring glutamate release from the TCA cycle was estimated. 
Regarding glutamine, the predicted isotopomer dynamics was a 
little slower than that experimentally observed. This might indicate 
a glutamine pool smaller than the measured value. The estimated 
flux through the reaction catalyzed by glutamine synthetase (r
36a
; 
Table 3) was slightly higher than the observed glutamine secre-
tion rate, resulting in some flux through the inverse reaction (r
36b
; 
Table 4).
Table 3 | Parameter values (fluxes and metabolite pools) which allowed 
the best fit to the mass isotopomer data.
  Fluxes 95% Confidence 
 (μmol mg prot−1 h−1) limit
r2 (G6P → F6P) 0.940 0.001
r32 (Mal → Pyr) 0.12 0.03
r34 (Mal–Asp shuttle) 0.16 0.08
r35a (α-ketoglutarate 0.32 0.06 
→ glutamate)
r36a (Glu → Gln) 0.052 0.002
r38 (Cys → Taur + Hyptaur) 0.17 0.02
 Pool size 95% Confidence 
 (μmol mg prot−1) limit
Citrate 0.05 0.02
α-Ketoglutarate 0.15 0.03
Malate 0.05 0.06
Fumarate 0.05 0.03
Glycolysis/PPP 0.027 0.001 
intermediates
The six free fluxes and five metabolite pools were estimated using an optimi-
zation routine (see Materials and Methods) that allowed finding the optimal 
values that better described the experimental data.
Table 4 | Astrocytic metabolic fluxes estimated using the isotopic 
transient MFA methodology.
reaction Flux (μmol mg prot−1 h−1)
r1 (Glc → G6P) (=rGlc)
1 1.06 ± 0.02
r3–r4 (F6P → 2GAP) 1.02 ± 0.03
r5–r9 (GAP → Pyr) 2.08 ± 0.03
r10 (Pyr → Ala) (=rAla)
1 0.042 ± 0.004
r11 (Pyr → Lac) (=rLac)
1 2.11 ± 0.04
r12–r14 (G6P → Ru5P) 0.12 ± 0.02
r15 (Ru5P → R5P) 0.04 ± 0.02
r16 (Ru5P → Xu5P) 0.08 ± 0.01
r17–r19 (R5P + 2 Xu5P → GAP + 2 F6P) 0.04 ± 0.01
r20 (Cys → Pyr) 0.16 ± 0.01
r21 (Pyr → OAA) (pyruvate carboxylase flux) 0.07 ± 0.02
r22 (Pyr → AcoA) (pyruvate dehydrogenase flux) 0.14 ± 0.07
r23 (ACoA + Oxa → Cit) 0.45 ± 0.08
r24–r27 (Cit → α-KG) 0.43 ± 0.08
r28 (α-ketoglutarate → SucCoa) 0.35 ± 0.08
r29–r31 (SucCoa → Mal) 0.51 ± 0.08
r33 (Mal → OAA) 0.39 ± 0.08
r35b (Glu → α-KG) 0.46 ± 0.07
r36b (Gln → Glu) 0.003 ± 0.003
r37 (Cys → GSH)
2 0.030 
r39 (Ile → AcoA + SucCoA) (=rIle)
1 −0.10 ± 0.05
r40 (Leu → AcoA) (=rLeu)
1 −0.11 ± 0.05
r41 (Val → Suc) (=rVal)
1 −0.053 ± 0.005
Citrate release rate2 0.025
The fluxes that are missing (r2, r32, r34, r35a, r36a, r38) correspond to the six free fluxes 
estimated through an optimization routine (see Materials and Methods) and are 
presented on Table 3.
1These rates correspond to those experimentally measured – see Table 1.
2Taken from the literature (Westergaard et al., 1994; O’Connor et al., 1995).
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between astrocytes and neurons would include a much larger num-
ber of reactions and, consequently, of unknown fluxes. This would 
require a larger set of experimental data and, in particular, the separate 
measurement of specific metabolic rates and pools for astrocytes and 
neurons, in order for the system to be determined. Still, this could be 
performed in a co-culture system, in which neurons and astrocytes 
could be physically separated (for example, using cell culture inserts).
The present methodology thus requires the use of sensitive 
techniques, such as MS, and considerable experimental work. 13C-
NMR spectroscopy can also be used, particularly when the labeled 
substrates yield more complex labeling patterns. However, its low 
sensitivity compared to MS becomes a disadvantage when the goal 
is to have labeling time-courses for as many metabolites as possible. 
In the present study, mass isotopomer data and metabolite pools 
were still limited to a relatively small number. Actually, quantifica-
tion of metabolite pools has been one of the major drawbacks of 
isotopic transient MFA. GC–MS provided only the relative isotopic 
enrichment of intracellular pools. To have absolute pool concen-
trations, difficult-to-obtain labeled standards would be required. 
Nevertheless, the number of quantifiable mass isotopomers and 
absolute pool concentrations is expected to increase as MS tech-
niques continue to improve. In addition, the high specificity of 1H 
NMR spectroscopy widely used in the metabolomics field (Weljie 
et al., 2006) could also be a good tool to quantify metabolite pools.
To investigate brain metabolism in the scope of larger (under-
determined) networks, another metabolite balancing approach 
called flux balance analysis (FBA) has been applied (Cakir et al., 
2007; Lewis et al., 2010). FBA relies on linear programming to 
obtain a solution for the intracellular fluxes in underdetermined 
systems (Kauffman et al., 2003). However, it requires the defini-
tion of a metabolic objective which is maximized or minimized 
during flux calculations (Kauffman et al., 2003). This metabolic 
objective might be hard to define, particularly concerning the com-
plex interactions between brain cells. Cakir et al. (2007) reported 
recently the application of FBA to investigate the metabolic inter-
actions between neurons and astrocytes using diverse metabolic 
objective functions. Comparing to literature findings the best flux 
prediction was achieved when the maximization of the glutamate–
glutamine-GABA cycle flux was the objective function (Cakir et al., 
2007). Also based on linear programming, Lewis et al. (2010) have 
recently reported a large-scale in silico model, including genomic 
and proteomic data, to recapitulate metabolic interactions between 
astrocytes and different types of neurons. This model correlates flux 
changes with altered expression or activity of particular enzymes 
(Lewis et al., 2010), representing a major breakthrough in this field, 
although it goes much beyond the scope of isotopic transient MFA.
estIMatIon oF Fluxes In parallel pathways: ppp/GlycolysIs and 
pc/pdh branch poInts
The PPP plays a key role in the maintenance of the cellular redox 
balance by ensuring the recycling of the reducing cofactor NADPH, 
necessary for the regeneration of glutathione, the major antioxidant 
molecule in brain cells (Dringen, 2000). In fact, the model takes 
some synthesis of glutathione from cysteine into account. Also 
based on the 45% enrichment in PEP and 3PG at isotopic steady-
state, the model estimated an 89:11% flux ratio between glycolysis 
and the PPP. Most of the available estimations of the PPP flux 
The fitting performance (defined by the objective function) is 
rather sensitive to the optimized parameters. Inversely, the pro-
posed parameter set is quite robust to variations in the fitting 
performance, revealing that even if reaching only a sub-optimal 
solution within the biologically relevant parameter space, the opti-
mal parameter set would be relatively closer to the sub-optimal one. 
This means that the deviations between model and experimental 
measurements have a small impact on flux estimations.
dIscussIon
13c IsotopIc transIent MFa vs. other ModelInG MethodoloGIes
In this work, a state-of-the-art metabolic modeling tool, isotopic 
transient 13C MFA (Wiechert and Noh, 2005), was applied for the 
first time to estimate intracellular fluxes of brain cells. This meth-
odology uses all the information contained in the isotopic transient 
data and, thus, the quality of flux estimations is strongly improved 
when compared to the classical MFA. The latter provides only the 
net fluxes (not the separate fluxes) through parallel metabolic path-
ways and reversible reactions. Isotopic transient 13C MFA allows the 
resolution of important branches of the metabolic network. This 
is the case for the fluxes of parallel pathways (glycolysis vs. PPP 
and PC vs. PDH), bidirectional reactions (the reversible exchange 
between α-ketoglutarate and glutamate and between glutamate and 
glutamine – see Figure 3), and cyclic pathways (MAS).
Isotopic transient MFA constitutes an improved, although more 
complex, alternative to the model pioneered by Malloy, which was ini-
tially developed to investigate heart metabolism (Malloy et al., 1988) 
and later adapted to estimate fluxes based on isotopomer composition 
of glutamate in neurons or glutamine in astrocytes (Martin et al., 
1993; Merle et al., 1996b). Nevertheless, both MFA/13C MFA and the 
Malloy model have only been applied to estimate fluxes in a single 
cellular compartment. A network describing metabolic interactions 
Figure 3 | Total metabolic fluxes at the glutamate/α-ketoglutarate node. The 
forward and reverse fluxes of α-ketoglutarate/glutamate exchange were calculated 
by summing up all fluxes of the reactions in which they are included. Values are 
µmol mg prot–1 h−1. a – The total flux α-ketoglutarate → glutamate is the sum of the 
fluxes r34, r35a, r39, r40, and r41. b – The total flux glutamate → α-ketoglutarate is the 
sum of the fluxes r35b, r34, and r10. Abbreviations: α-KG, α-ketoglutarate; Gln, 
glutamine; Glu, glutamate; GSH, glutathione; OSuc, oxalosuccinate; SucCoA, 
succinyl-Coenzyme A.
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glutamine synthesis also in the resting human brain (Gruetter et al., 
1998) and its contribution was estimated to be 35% by metabolic 
modeling (Gruetter et al., 2001). Also, Duarte et al. (2011) very 
recently estimated a 25% contribution of PC to the glial TCA cycle 
rate in the rat brain and a PC/PDH ratio of 30% for the glial com-
partment. Even though the absence of neurons might reduce the 
need of glutamine synthesis by a monotypic culture of astrocytes, 
our results suggest that PC also significantly contributes to glu-
tamine synthesis in this context.
tca cycle Fluxes and bcaas catabolIsM
The TCA cycle fluxes estimated in this work are in the range of val-
ues previously estimated by us using the classic MFA methodology 
(Teixeira et al., 2008; Amaral et al., 2010). The estimated reduction 
in 13C enrichment from 41% in pyruvate to 14% in acetyl-CoA cor-
roborates a study by Merle et al. (1996b) in cerebellar astrocytes. 
These authors justified the label dilution of acetyl-CoA with the 
consumption of extracellular amino acids and fatty acid degrada-
tion (Merle et al., 1996b). Our model considers also the metabo-
lism of BCAA as an additional source of acetyl-CoA and elevated 
uptake rates (when comparing to the flux obtained for PDH) were 
measured for these amino acids. Actually, 14% enrichment in glu-
tamate isotopomers produced after one turn of the TCA cycle was 
observed after incubation of astrocytes with [U-13C]isoleucine 
(56% enriched in the medium; Johansen et al., 2007) confirming 
that BCAAs are oxidized to a large extent.
The role of BCAAs as energy fuels is also relevant in vivo. It has 
been shown that these substrates are oxidized by astrocytes in the 
rat brain to a significant extent (Dienel and Cruz, 2009). Additional 
findings indicate that BCAAs also contribute to the “glutamine 
dilution” phenomenon observed in 13C isotopomer studies (Cruz 
et al., 2007; Dienel and Cruz, 2009). However, BCAAs taken up by 
astrocytes can also be metabolized into ketone bodies, which are 
subsequently released and can eventually be taken up by neurons 
(Bixel and Hamprecht, 1995). Thus, we cannot exclude a slightly 
overestimation of the TCA cycle fluxes as well as the fluxes through 
the reactions bridging glycolysis and TCA cycle. Experimental labe-
ling time-courses of intracellular lactate and/or pyruvate (which 
were not possible to obtain in the present study) would enable more 
accurate estimations at this metabolic node.
Glycolytic metabolites reached isotopic steady-state much faster 
than TCA cycle-related metabolites, which can be due to the large 
pools of glutamate and aspartate (Table 1). These are linked to the 
TCA cycle through reversible aminotransferase reactions, delaying 
the labeling time-courses of TCA cycle metabolites. This is clearly 
observed in the labeling time-course of the citrate pool, which is 
faster during the first 30 min of incubation. Then, it becomes slower 
as it is more dependent on the labeling dynamics of the downstream 
metabolites and subsequent turns of the TCA cycle. The model could 
describe this phenomenon quite well. The lower enrichment observed 
for fumarate, when compared to citrate, can be explained by the fun-
neling of BCAAs from the incubation medium into the TCA cycle 
at the succinyl-CoA node, which dilutes the labeled fraction of the 
downstream compounds. On the other hand, the higher enrichment 
in aspartate and malate compared to that of fumarate is explained 
by the flux through PC. PC converts pyruvate into oxaloacetate that, 
subsequently, might exchange 13C label with malate to a significant 
were carried out using data from in vitro studies. Fitting with the 
present results, using the classical MFA combined with 13C labeling 
data collected at isotopic steady-state, we have recently estimated 
that ∼10% of the total glucose consumed was metabolized through 
the PPP in astrocytes cultured in stirred bioreactors (Amaral et al., 
2010). Previously, Ben-Yoseph et al. (1996) had reported a basal 
astrocytic PPP flux of ∼7% of the total lactate produced from glu-
cose in cultured astrocytes, determined by a GC–MS method based 
on the differential labeling of released lactate following metabo-
lism of [1,6-C
2
,6,6-2H
2
]glucose. This value increased to 67% during 
exposure to oxidative stress (Ben-Yoseph et al., 1996). A PPP flux 
of 7% has also been reported in healthy human subjects using 
[1,2-13C]glucose and 13C-NMR spectroscopy (Dusick et al., 2007). 
The importance of considering the PPP in modeling studies and of 
providing better tools to estimate its flux is justified by its significant 
influence on estimations of the glutamate–glutamine cycle in vivo 
(Shen et al., 2009). In addition, experimental data obtained in the 
context of brain activation studies in rats provided further evidence 
that the PPP might contribute more than previously estimated to 
the “glutamine dilution” phenomenon (Cruz et al., 2007; Dienel 
and Cruz, 2009).
Still, we cannot exclude that minor glycogen degradation 
could also have influenced the observed enrichment in glycolytic 
intermediates. In fact, lactate released by astrocytes was shown to 
partially result from glycogen breakdown, even in the presence of 
glucose (Sickmann et al., 2005). Nevertheless, the role of glycogen 
as energy fuel appears to be more significant in the context of brain 
activation (Dienel et al., 2007). Glycogenolysis was not included 
in the model due to the lack of experimental data enabling us to 
distinguish between the contribution from the glycogen shunt and 
the PPP to PEP and 3PG 13C time-courses. More isotopomer time-
courses would be required, for example, those from glucose or 
glucose-6-phosphate and intermediates of the PPP. It was decided 
to include the PPP instead of the glycogen shunt since it is more 
likely that this pathway accounts for the label dilution observed in 
glycolysis. The PPP is required for maintaining the basal cellular 
redox balance (Dringen, 2000), even when significant oxidative 
stress is not present.
Pyruvate carboxylation is an important anaplerotic reaction in 
the brain and is thought to occur predominantly in astrocytes due 
to the specific glial localization of the PC enzyme (Shank et al., 
1985). The PC/PDH ratio is usually estimated based on the different 
metabolite isotopomers, such as glutamate or glutamine, originat-
ing from [13C]glucose metabolism through each of these pathways. 
In this work, the PC/PDH ratio (0.5) was calculated directly from 
the estimated PC and PDH fluxes, based on total carbon fluxes 
and not only on the 13C fluxes coming from glucose. This PC/
PDH ratio fits well with those determined in vitro (Hassel et al., 
1995; Waagepetersen et al., 2001) and also in vivo (Gruetter et al., 
2001; Merle et al., 2002; Oz et al., 2004) for the glial compartment. 
Interestingly, Merle et al. (1996b) estimated a PC/PDH ratio of 0.54 
in cultured cerebellar astrocytes and a similar value was obtained 
by us (Teixeira et al., 2008) in cultured cortical astrocytes. Taking 
into account the measured rates of release of different metabolites, 
the present results confirm that PC significantly contributes to the 
release of citrate and glutamine from astrocytes (Waagepetersen 
et al., 2001). Moreover, the PC flux is known to be implicated in 
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The decarboxylation reaction by malic enzyme was also 
included in the model and its flux represented about 5% of 
the fluxes leading to pyruvate synthesis. Pyruvate formed via 
malic enzyme must re-enter the TCA cycle to be completely oxi-
dized. This pathway is called pyruvate recycling and has been 
described both in vitro (Sonnewald et al., 1996; Bakken et al., 
1997; Waagepetersen et al., 2002) and in vivo (Cerdan et al., 1990; 
Haberg et al., 1998). As discussed by Waagepetersen et al. (2002), 
this pathway is likely to be more active when cells need to dis-
pose of glutamate and glutamine by oxidative degradation. The 
preferential release α-ketoglutarate via glutamate from the TCA 
cycle and subsequent production of glutamine observed in this 
work thus explains the low contribution of this flux to the total 
pyruvate production.
Also related to pyruvate synthesis is the degradation of 
cysteine. There are not many published values for these 
rates. Beetsch and Olson (1998) reported a rate of [35S]tau-
rine synthesis from [35S]cysteine in cultured rat astrocytes of 
1.27 nmol mg prot−1 h−1, which is much lower than that esti-
mated in this work (0.17 μmol mg prot−1 h−1). However, in the 
same study, the measured activity of the rate-limiting enzyme 
involved in cysteine degradation into taurine, cysteine dioxyge-
nase, was 144 nmol mg prot−1 h−1, which fits well with the taurine/
hypotaurine synthesis rate estimated by our model. These results 
are also supported by findings from Brand et al. (1998) showing 
that cultured astrocytes mainly use cysteine for the synthesis of 
taurine and hypotaurine as observed by 13C-NMR spectroscopy 
after incubation with [3-13C]cysteine (Brand et al., 1998). Still, 
Beetsch and Olson (1998) observed that taurine synthesis from 
extracellular cysteine is also supported by a robust rate of cysteine 
accumulation, and thus we cannot exclude that this factor might 
have contributed to the overestimation of the rate, as some of 
the cysteine taken up could have been accumulated to later yield 
taurine/hypotaurine. Nevertheless, this would not have an impact 
on the remaining estimated fluxes.
FInal reMarks
This work clearly shows the potential of 13C isotopic transient 
MFA to provide a reliable metabolic profile of cultured astrocytes 
in a variety of conditions. Important metabolic fluxes of astrocytes 
normally not easily accessible were estimated, namely the PPP, 
PC, PDH, TCA cycle, MAS, and also the α-ketoglutarate/gluta-
mate exchange fluxes. In addition to corroborating in vivo and 
in vitro findings reported in the literature, this work also sheds 
new light on the important contribution of non-glucose carbon 
sources to the global carbon fluxes of astrocytic energy metabo-
lism, even under resting conditions. In summary, 13C isotopic 
transient MFA allows for the integration of the high amount of 
metabolomics data being generated and for an increased resolu-
tion of estimated fluxes. Due to its flexibility, the structure of the 
model is easy to adapt to a neuronal metabolic network or even to 
a co-culture system in which the different cellular compartments 
can be  separated. Depending on the choice of the 13C-labeled 
substrate(s), this tool will allow the in vitro investigation of rel-
evant aspects of cerebral bioenergetics, including specific meta-
bolic disease hallmarks, which can provide important clues to 
help understanding in vivo data.
extent through “back-cycling” in the TCA cycle (Sonnewald et al., 
1993; Merle et al., 1996b). Actually, we have evidence that extensive 
malate to fumarate back-flux occurs in cultured astrocytes (unpub-
lished data). In addition, the MAS activity further explains the iso-
topomer distribution similarity between malate and aspartate pools.
Malate–aspartate shuttle and GlutaMate/α-ketoGlutarate 
exchanGe
The link between oxidative glucose metabolism and glutamate labe-
ling is established by an active exchange rate between α-ketoglutarate 
and glutamate pools (a flux normally represented by Vx), which is, 
together with the oxaloacetate/aspartate exchange, mediated by the 
MAS (Gruetter et al., 2003). NADH is produced in glycolysis at the 
same rate of pyruvate synthesis. In order to maintain the cytosolic 
redox balance required for the continuous operation of glycoly-
sis it needs to be recycled back to NAD+ (McKenna et al., 2006). 
Thus, reducing equivalents from NADH are transported into the 
mitochondrion by the MAS and are oxidized at the same rate that 
pyruvate enters the TCA cycle (Gruetter et al., 2003). This justifies 
the role of the MAS in mediating the exchange of label across the 
mitochondrial membrane (Gruetter et al., 2003). In fact, our results 
agree with this direct relationship between the pyruvate oxidation 
rate, i.e., the rate of pyruvate entry in the TCA cycle – PDH + PC 
(0.21 ± 0.08 μmol mg prot−1 h−1) and the MAS (0.16 ± 0.08 μmol 
mg prot−1 h−1) flux.
Still, a large debate exists concerning the relative magnitude 
of the V
x
 and PDH fluxes in the brain. Whereas some authors 
provided evidence that V
x
 and PDH fluxes are in the same range 
(Gruetter et al., 2001; Choi et al., 2002; Henry et al., 2002), oth-
ers have proposed that V
x
 rate should be much higher than PDH 
(Mason et al., 1992, 1995). A scheme describing all reactions 
linked to glutamate and α-ketoglutarate pools and their corre-
sponding estimated fluxes can be seen in Figure 3. Our approach 
allowed distinguishing between these reversible fluxes, taking into 
account all carbon sources involved in α-ketoglutarate and glu-
tamate metabolism. The present work importantly provides new 
evidence that V
x
 is in the range of the TCA cycle fluxes and not 
several fold higher. It should be highlighted that most of the cited 
investigations refer to whole brain fluxes whereas this study is 
focused only on astrocytic metabolic fluxes, although obtained 
from primary cultures. Nevertheless, Duarte et al. (2011) have 
recently reported new supporting evidence for this concept, using 
an improved model allowing to estimate V
x
 in both the neuronal 
and glial compartment in the rat brain in vivo. Taken together, 
these findings support the importance of the present results as 
reflecting what could be happening in the astrocytic compart-
ment in vivo.
pyruvate coMpartMentatIon and MalIc enzyMe
Different labeling time-courses between extracellular lactate and 
alanine can be interpreted based on the existence of distinct astro-
cytic pyruvate pools. Labeling of alanine from glucose was previ-
ously observed to be lower than that of lactate in astrocyte cultures 
(Brand et al., 1992, 1993), which corroborates our results. These 
observations can additionally explain the poor fitting of the model 
to alanine experimental 13C time-courses, since the model does not 
take into account distinct metabolite pools.
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Amino acids metabolism
 36a. Glu → Gln
 36b. Gln → Glu
 37. Glu + Cys + Gly → GSH
 38. Cys → Taur + Hyptaur
 39. Ile + α-KG + 2 CoA → SuCoA + ACoA + Glu
 40. Leu + α-KG + 2 CoA → 2 ACoA + Glu + CO2
 41. Val + α-KG + CoA → SuCoA + Glu + CO2
 20. Cys → Pyr
Transport reactions from cell supernatant
 Glcext → Glc
 Ala → Alaext
 Lac → Lacext
 Cit → Citext
 Cystext → 2 Cys
 Gln → Glnext
 Ileext → Ile
 Leuext → Leu
 Valext → Val
Mass IsotopoMer balances oF MetabolItes represented In the 
MetabolIc network (FIGure 1)
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appendIx
stoIchIoMetrIc MatrIx (MetabolIc reactIons) oF the Model 
descrIbInG astrocytIc MetabolIsM1
glycolysis
 1. Glc → G6P
 2. G6P → F6P
 3. F6P → FBP
 4. F6P → 2 GAP
 5. GAP → BPG
 6. BPG → 3PG
 7. 3PG → 2PG
 8. 2PG → PEP
 9. PEP → Pyr
 10. Pyr + Glu → Ala + α-KG
 11. Pyr → Lac
Pentose phosphate pathway
 12. G6P → 6PGL
 13. 6PGL → 6PG
 14. 6PG → Ru5P + CO2
 15. Ru5P → R5P
 16. Ru5P → Xu5P
 17. R5P + Xu5P → GAP + S7P
 18. GAP + S7P → F6P + E4P
 19. Xu5P + E4P → GAP + F6P
TCA cycle and related reactions
 21. Pyr + CO2 → OAAm
 22. Pyr + CoA → ACoA + CO2
 23. OAAm + ACoA → Cit + CoA
 24. Cit → Aco
 25. Aco → Isocit
 26. Isocit → OSuc
 27. OSuc → α-KG + CO2
 28. α-KG + CoA → SuCoA + CO2
 29. SuCoA → Succ + CoA
 30. Succ → Fum
 31. Fum → Mal
 32. Mal → Pyr + CO2
 33. Mal → OAAm
 34a. OAAm → Aspm
 34b. Aspm + Glu → Aspc + α-KG
 34c. ASpc + α-KG → OAAc + Glu
 34d. OAAc → Mal
 35a. α-KG → Glu
 35b. Glu → α-KG
1Only carbon stoichiometry is considered since 13C isotopic transient MFA does not 
require balancing of cofactors or ATP to estimate metabolic fluxes. Abbreviations: Glc, 
glucose; G6P, glucose-6-phosphate; F6P, fructose-6-phosphate; DHAP, Dihydroxy-
acetone phosphate; GAP, glyceraldehyde-3-phosphate; BPG, 1:3-bis-phosphoglycera-
te; 3PG, 3-phosphoglycerate, 2PG, 2-phosphoglycerate; PEP, phosphoenolpyruvate; 
PYR, pyruvate; 6PGL, 6-phospho-gluconolactone; 6PG, 6-phosphogluconate; Ru5P, 
ribulose-5-phosphate; R5P, ribose-5-phosphate; Xu5P, xylulose-5-phosphate; S7P, se-
doheptulose-7-phosphate; E4P, erythrose-4-phosphate; Lac, lactate; Glu, glutamate; 
ACoA, Acetyl-Coenzyme A; Cyst, cystine; Cys, cysteine; Gly, glycine; GSH, glutathio-
ne; Ala, alanine; α-KG, α-ketoglutarate; OAA
m
, oxaloacetate – mitochondrial pool; 
OAA
c
, oxaloacetate – cytosolic pool; Cit, Citrate; Aco, cis-aconitate; Isocit, isocitrate; 
OSuc, oxalosuccinate; SucCoA, succinyl-coenzyme A; Succ, succinate; Fum, fuma-
rate; Mal, malate; Asp
m
, aspartate – mitochondrial pool; Asp
c
, aspartate – cytosolic 
pool; Gln, glutamine; Leu, leucine; Ile, isoleucine; Val, valine; Lys, lysine; ext refers to 
metabolites taken up from/released to the culture supernatant.
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